Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.
Shufang LiaoBin ZhangYixin SuYufei PanJian ZhangZhenkai YeRongjun ZhangXiangyun KongGuanjie QinYunyan MoXiaolan RuanJian LiuChunqiao GanJinxuan DaiRuyun ZhangGuanhong LuoXiaofei LiaoWei JiangPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Adding CC to IMRT provided no survival benefit but increased treatment-associated toxicities in patients with intermediate-risk NPC.